Table 3.
Factors associated with survival among patients with local staged NSCLC (n = 185)
| HR | χ2 | P | |
|---|---|---|---|
| Sex | |||
| Female | 0.64 | 3.36 | 0.07 |
| Male | Ref | ||
| Race | |||
| Black | 1.78 | 4.42 | 0.04 |
| White | Ref | ||
| Age group, y | |||
| <50 | 0.23 | 2.03 | 0.15 |
| 50–64 | 0.43 | 7.07 | 0.01 |
| 65–74 | 0.61 | 3.39 | 0.07 |
| ≥75 | Ref | ||
| Histology | |||
| Squamous cell carcinoma | 1.28 | 0.59 | 0.44 |
| Non–small-cell carcinoma | 3.68 | 12.07 | <0.001 |
| Other | 0.93 | 0.58 | 0.81 |
| Adenocarcinoma | Ref | ||
| Timely | |||
| Yes | 0.98 | 0.01 | 0.94 |
| No | Ref | ||
Values in boldface type indicates significance at α = 0.05. HR, hazard ratio; NSCLC, non–small-cell lung cancer.